Search
for

    Sort by

    Research 31–60 of 106

    1. EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS Revista Ibero-Americana de Humanidades, Ciências e Educação · 2026
    2. Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review Wound Repair and Regeneration · 2025
    3. The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe? Biomolecules · 2025 · 4 citations
    4. Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series Life · 2026
    5. ¿Novedad o prudencia? El delicado equilibrio en la actualización farmacológica Actualización en Medicina de Familia · 2025
    6. Farmácia Avenida Brasil, Porto Open Repository of the University of Porto (University of Porto) · 2023
    7. Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons Dermatology and Therapy · 2025 · 1 citations
    8. Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study EMJ Dermatology · 2025
    9. Repurposing existing drugs for COVID-19: an endocrinology perspective BMC Endocrine Disorders · 2020 · 34 citations
    10. Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome Cureus · 2024 · 10 citations
    11. Pharmacological management of polycystic ovary syndrome Australian Prescriber · 2024 · 9 citations
    12. Clinical manifestations of polycystic ovary syndrome Medicinska istrazivanja · 2024 · 7 citations
    13. POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE Anti-Aging Eastern Europe · 2024 · 2 citations
    14. Ether: Fiction or Reality? A Review Biomedical Journal of Scientific & Technical Research · 2025 · 1 citations
    15. From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries International Journal on Science and Technology · 2026
    16. Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation Frontiers in Pharmacology · 2026
    17. INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH Anti-Aging Eastern Europe · 2026
    18. Polycystic ovary syndrome: An update on diagnosis and management Cleveland Clinic Journal of Medicine · 2026
    19. Plant-based approaches in the management of polycystic ovary syndrome: A review Journal of Pharmacognosy and Phytochemistry · 2025
    20. Holistic management plan for polycystic ovarian syndrome (PCOS): A systematic literature review International Journal of Clinical Obstetrics and Gynaecology · 2025
    21. Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome Journal of Neonatal Surgery · 2025
    22. Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome 2025
    23. Understanding Polycystic Ovary Syndrome Directory of Open access Books (OAPEN Foundation) · 2025
    24. Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report Cureus · 2024
    25. Polycystic Ovarian Disease: Current Insights and therapeutic Strategies African Journal of Biomedical Research · 2024
    26. Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional e_Buah · 2023
    27. Endocrinologia e Medicina Estética Ed. X Editora Pasteur eBooks · 2026
    28. Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto Open Repository of the University of Porto (University of Porto) · 2025
    29. Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha Open Repository of the University of Porto (University of Porto) · 2024
    30. Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review Cureus · 2025